Recent progress on engineered micro/nanomaterials mediated modulation of gut microbiota for treating inflammatory bowel disease

Inflammatory bowel disease (IBD) is a type of chronic recurrent inflammation disease that mainly includes Crohn's disease and ulcerative colitis. Currently, the treatments for IBD remain highly challenging, with clinical treatment drugs showing limited efficacy and adverse side effects. Thus, d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of controlled release 2024-06, Vol.370, p.43-65
Hauptverfasser:	Kan, Lingling, Zheng, Ziwen, Fu, Wanyue, Ma, Yan, Wang, Wanni, Qian, Haisheng, Xu, Lingling
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals bioavailability Crohn disease drugs flora Gastrointestinal Microbiome Gut microbiota homeostasis Humans immune system inflammation Inflammatory bowel disease Inflammatory Bowel Diseases - drug therapy Inflammatory Bowel Diseases - microbiology Inflammatory Bowel Diseases - therapy intestinal microorganisms intestines nanomaterials Nanostructures - administration & dosage Prebiotics Prebiotics - administration & dosage Probiotics Probiotics - administration & dosage Probiotics - therapeutic use Redox-active micro/nanomaterials therapeutics toxicity ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!